Skip to main content
Fig. 1 | Malaria Journal

Fig. 1

From: Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study

Fig. 1

Titers to P. falciparum and P. vivax MSP142 by site and clinical history. Antibody titers to P. falciparum MSP142 (a, c) and Pv MSP142 (b, d) in smear-negative volunteers at screening. a, b Titers grouped according to site: site A (n = 113) versus site B (n = 101) while c, d show titers at each site according to time since most recent malaria infection (any species): within past year, more than 1 year ago and never. c, d Also include the percent of seropositive volunteers in each timing category and site. Black line is geomean titer for each site, while the blue line represents cutoff titer for seropositivity

Back to article page